Quick Answer
IMPACT BIOMEDICAL INC. reported Cash and Equivalents of $3.0 thousand for fiscal year 2025.
IMPACT BIOMEDICAL INC. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $3.0K | -99.8% |
| 2024 | $2.00M | +199800.0% |
| 2023 | $1.0K | -50.0% |
| 2022 | $2.0K | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $12.0K | -99.6% | -98.1% |
| June 30, 2025 | $624.0K | +31100.0% | -52.7% |
| March 31, 2025 | $1.32M | +65800.0% | -34.1% |
| December 31, 2024 | $2.00M | +199800.0% | -25.1% |
| September 30, 2024 | $2.67M | +1227.4% | +133300.0% |
| June 30, 2024 | $2.0K | -33.3% | +0.0% |
| March 31, 2024 | $2.0K | — | +100.0% |
| December 31, 2023 | $1.0K | -50.0% | -99.5% |
- IMPACT BIOMEDICAL INC. showed a decrease of -99.8% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2022–2025 period, IMPACT BIOMEDICAL INC.’s cash and equivalents has grown by 50.0% (from $2.0 thousand to $3.0 thousand).
- The most recent figure is from IMPACT BIOMEDICAL INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 11, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: